• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体端粒酶过表达对肝癌耐药性的影响。

Impact of mitochondrial telomerase over-expression on drug resistance of hepatocellular carcinoma.

机构信息

Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University No. 83 Xiqiaozheng Street, Chongqing 400037, China.

出版信息

Am J Transl Res. 2015 Jan 15;7(1):88-99. eCollection 2015.

PMID:25755831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4346526/
Abstract

BACKGROUND

The efficacy of chemotherapy in patients with hepatocellular carcinomas still poor due to multidrug resistance. This study aimed to investigate the impact of the over-expressed mitochondrial human telomerase reverse transcriptase on multidrug resistance of hepatocellular carcinomas.

METHODS

HepG2 and SK-Hep1 cell lines were used. And sensitivity to chemotherapeutic drugs was detected.

RESULTS

Mitochondrial human telomerase reverse transcriptase over-expression in hepatocellular carcinomas cells could significantly reduce its sensitivity to multiple chemotherapeutic drugs in vitro and in vivo. Hepatocellular carcinomas cells over-expressing mitochondrial human telomerase reverse transcriptase showed a significantly higher mitochondrial membrane potential, a markedly lower activated caspase-3 after drug treatment, and an increased mtDNA copy number, which explained the drastically decreased drug-induced apoptosis of hepatocellular carcinomas cells with mitochondrial human telomerase reverse transcriptase over-expression.

CONCLUSION

Over-expressed mitochondrial human telomerase reverse transcriptase may increase the mtDNA copy number and inhibit the activation of mitochondrial apoptotic pathway to contribute to the multidrug resistance of hepatocellular carcinomas cells.

摘要

背景

由于多药耐药性,化疗在肝细胞癌患者中的疗效仍然不佳。本研究旨在探讨过度表达的线粒体人端粒酶逆转录酶对肝癌多药耐药性的影响。

方法

使用 HepG2 和 SK-Hep1 细胞系。并检测对化疗药物的敏感性。

结果

肝癌细胞中线粒体人端粒酶逆转录酶的过度表达可显著降低其在体外和体内对多种化疗药物的敏感性。过表达线粒体人端粒酶逆转录酶的肝癌细胞表现出明显更高的线粒体膜电位,药物处理后激活的 caspase-3 明显降低,以及 mtDNA 拷贝数增加,这解释了线粒体人端粒酶逆转录酶过度表达导致肝癌细胞中药物诱导的凋亡明显减少。

结论

过度表达的线粒体人端粒酶逆转录酶可能会增加 mtDNA 拷贝数并抑制线粒体凋亡途径的激活,从而导致肝癌细胞的多药耐药性。

相似文献

1
Impact of mitochondrial telomerase over-expression on drug resistance of hepatocellular carcinoma.线粒体端粒酶过表达对肝癌耐药性的影响。
Am J Transl Res. 2015 Jan 15;7(1):88-99. eCollection 2015.
2
Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance.端粒酶线粒体易位在多药耐药肝癌细胞中的作用。
Int J Med Sci. 2012;9(7):545-54. doi: 10.7150/ijms.4648. Epub 2012 Aug 30.
3
Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells.端粒酶线粒体易位对肝癌细胞耐药性的影响。
J Cancer. 2015 Jan 5;6(2):151-9. doi: 10.7150/jca.10419. eCollection 2015.
4
Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.乙型肝炎病毒核心蛋白以 c-Ets2 依赖的方式增强端粒酶逆转录酶表达并促进肝癌细胞增殖。
Int J Biochem Cell Biol. 2013 Jul;45(7):1174-85. doi: 10.1016/j.biocel.2013.03.015. Epub 2013 Mar 27.
5
Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.小分子c-Myc抑制剂10058-F4可抑制人肝癌细胞增殖,下调人端粒酶逆转录酶并增强其化学敏感性。
Anticancer Drugs. 2007 Feb;18(2):161-70. doi: 10.1097/CAD.0b013e3280109424.
6
Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells.低剂量顺铂上调hTERT表达有助于人肝癌细胞产生化疗耐药性。
Oncol Rep. 2009 Sep;22(3):549-56. doi: 10.3892/or_00000470.
7
Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells.由人端粒酶逆转录酶启动子表达肿瘤坏死因子相关凋亡诱导配体基因的纤维修饰腺病毒载体可诱导人肝癌细胞凋亡。
World J Gastroenterol. 2005 May 7;11(17):2552-6. doi: 10.3748/wjg.v11.i17.2552.
8
Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.端粒酶依赖性病毒疗法通过消除髓细胞白血病-1克服肝细胞癌对化疗和肿瘤坏死因子相关凋亡诱导配体的抗性。
Cancer Res. 2005 Aug 15;65(16):7393-402. doi: 10.1158/0008-5472.CAN-04-3664.
9
MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells.MEK抑制剂增强多药耐药肝癌细胞对化疗药物的敏感性。
Oncol Lett. 2017 Sep;14(3):3089-3095. doi: 10.3892/ol.2017.6494. Epub 2017 Jun 30.
10
Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.非环状维甲酸诱导人肝癌衍生细胞系部分分化,下调端粒酶逆转录酶mRNA表达和端粒酶活性,并诱导其凋亡。
J Hepatol. 2002 May;36(5):660-71. doi: 10.1016/s0168-8278(02)00044-2.

引用本文的文献

1
The Role of Telomerase in Breast Cancer's Response to Therapy.端粒酶在乳腺癌对治疗的反应中的作用。
Int J Mol Sci. 2022 Oct 25;23(21):12844. doi: 10.3390/ijms232112844.
2
Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.比较神经酰胺组学分析揭示阿霉素敏感和耐药 MCF-7 细胞之间的显著差异。
PLoS One. 2021 Oct 12;16(10):e0258363. doi: 10.1371/journal.pone.0258363. eCollection 2021.
3
Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma.探索端粒酶逆转录酶与β-连环蛋白在肝细胞癌中的相互作用
Cancers (Basel). 2021 Aug 20;13(16):4202. doi: 10.3390/cancers13164202.
4
The non-canonical functions of telomerase: to turn off or not to turn off.端粒酶的非经典功能:关闭还是不关闭。
Mol Biol Rep. 2019 Feb;46(1):1401-1411. doi: 10.1007/s11033-018-4496-x. Epub 2018 Nov 17.
5
Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.非透明细胞型和透明细胞型肝细胞癌中端粒酶的启动子突变及细胞分布
Oncotarget. 2017 Apr 18;8(16):26288-26297. doi: 10.18632/oncotarget.15458.

本文引用的文献

1
Mitochondrial regulation of cell death.线粒体调控细胞死亡。
Cold Spring Harb Perspect Biol. 2013 Sep 1;5(9):a008706. doi: 10.1101/cshperspect.a008706.
2
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.miR-508-5p 通过靶向 ABCB1 和 ZNRD1 调节胃癌的多药耐药性。
Oncogene. 2014 Jun 19;33(25):3267-76. doi: 10.1038/onc.2013.297. Epub 2013 Jul 29.
3
Mitochondria and tumor progression in ulcerative colitis.线粒体与溃疡性结肠炎中的肿瘤进展。
J Natl Cancer Inst. 2013 Aug 21;105(16):1239-48. doi: 10.1093/jnci/djt167. Epub 2013 Jul 12.
4
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.胃癌中抗癌药物的化疗敏感性与端粒酶逆转录酶 mRNA 表达的相关性。
Diagn Pathol. 2013 Feb 22;8:33. doi: 10.1186/1746-1596-8-33.
5
Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis.线粒体端粒酶保护癌细胞免受核 DNA 损伤和细胞凋亡。
PLoS One. 2013;8(1):e52989. doi: 10.1371/journal.pone.0052989. Epub 2013 Jan 9.
6
Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance.端粒酶线粒体易位在多药耐药肝癌细胞中的作用。
Int J Med Sci. 2012;9(7):545-54. doi: 10.7150/ijms.4648. Epub 2012 Aug 30.
7
Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria.人类端粒酶在粒体中作为一种 hTR 非依赖性逆转录酶发挥作用。
Nucleic Acids Res. 2012 Jan;40(2):712-25. doi: 10.1093/nar/gkr758. Epub 2011 Sep 21.
8
Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma.肝细胞癌凋亡抵抗分子成像的潜在靶点
Biomed Imaging Interv J. 2011 Jan-Mar;7(1):e5. doi: 10.2349/biij.7.1.e5. Epub 2011 Jan 1.
9
RNA-dependent RNA polymerases in RNA silencing.RNA 依赖的 RNA 聚合酶在 RNA 沉默中的作用。
Biol Chem. 2011 Apr;392(4):299-304. doi: 10.1515/BC.2011.035. Epub 2011 Feb 7.
10
hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells.端粒酶逆转录酶过表达可减轻细胞内 ROS 产生,改善线粒体功能,并抑制 ROS 介导的癌细胞凋亡。
Cancer Res. 2011 Jan 1;71(1):266-76. doi: 10.1158/0008-5472.CAN-10-1588. Epub 2010 Nov 11.